Published in Cancer on November 08, 2010
Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison. J Clin Oncol (2015) 2.93
Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol (2012) 2.33
Cancer- and cancer treatment-associated cognitive change: an update on the state of the science. J Clin Oncol (2012) 1.99
Ovarian cycle effects on immediate reward selection bias in humans: a role for estradiol. J Neurosci (2014) 1.53
Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. J Clin Oncol (2012) 1.49
An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol (2011) 1.32
Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry (2014) 1.30
Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study. Brain Behav Immun (2012) 1.27
Brain vulnerability to chemotherapy toxicities. Psychooncology (2012) 1.11
Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity? J Clin Oncol (2014) 1.00
Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know? Semin Oncol (2013) 0.99
Cognitive effects of cancer systemic therapy: implications for the care of older patients and survivors. J Clin Oncol (2014) 0.91
Apolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast cancer. Oncol Nurs Forum (2014) 0.85
Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking. Psychooncology (2014) 0.84
Brain network alterations and vulnerability to simulated neurodegeneration in breast cancer. Neurobiol Aging (2015) 0.83
Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future research. Brain Imaging Behav (2013) 0.83
Broadening the cancer and cognition landscape: the role of self-regulatory challenges. Psychooncology (2013) 0.81
Proposed mechanisms for cancer- and treatment-related cognitive changes. Semin Oncol Nurs (2013) 0.80
Breast cancer survivorship symptom management: current perspective and future development. Breast Cancer Manag (2013) 0.79
Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer. Neuro Oncol (2015) 0.79
COMT, BDNF, and DTNBP1 polymorphisms and cognitive functions in patients with brain tumors. Neuro Oncol (2016) 0.78
Neurocognitive functioning and genetic variation in patients with primary brain tumours. Lancet Oncol (2016) 0.77
Antioxidant enzyme polymorphisms and neuropsychological outcomes in medulloblastoma survivors: a report from the Childhood Cancer Survivor Study. Neuro Oncol (2012) 0.77
Investigating the relationship between COMT polymorphisms and working memory performance among childhood brain tumor survivors. Pediatr Blood Cancer (2013) 0.76
Chemotherapy-related cognitive impairment in older patients with cancer. J Geriatr Oncol (2016) 0.76
Biomarkers Associated with Cognitive Impairment in Treated Cancer Patients: Potential Predisposition and Risk Factors. Front Pharmacol (2017) 0.75
An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors. Breast Cancer (Dove Med Press) (2017) 0.75
A systemic literature review of neuroimaging studies in women with breast cancer treated with adjuvant chemotherapy. Contemp Oncol (Pozn) (2017) 0.75
A clinically relevant dose of cyclophosphamide chemotherapy impairs memory performance on the delayed spatial alternation task that is sustained over time as mice age. Neurotoxicology (2016) 0.75
Associations between catecholaminergic, GABAergic, and serotonergic genes and self-reported attentional function in oncology patients and their family caregivers. Eur J Oncol Nurs (2014) 0.75
Cognitive impairment following hormone therapy: current opinion of research in breast and prostate cancer patients. Curr Opin Support Palliat Care (2016) 0.75
Cognitive Effects of Chemotherapy and Cancer-Related Treatments in Older Adults. Am J Geriatr Psychiatry (2017) 0.75
Mechanisms of Neurotoxic Symptoms as a Result of Breast Cancer and Its Treatment: Considerations on the Contribution of Stress, Inflammation, and Cellular Bioenergetics. Curr Breast Cancer Rep (2017) 0.75
Construct validity of the five facet mindfulness questionnaire in meditating and nonmeditating samples. Assessment (2008) 3.93
Physical and psychological long-term and late effects of cancer. Cancer (2008) 2.45
Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol (2012) 2.33
Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol (2009) 2.31
Further validation of the multidimensional fatigue symptom inventory-short form. J Pain Symptom Manage (2004) 2.07
Are psychological interventions effective and accepted by cancer patients? II. Using empirically supported therapy guidelines to decide. Ann Behav Med (2006) 1.96
Outcomes of mild cognitive impairment by definition: a population study. Arch Neurol (2011) 1.84
Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psychooncology (2009) 1.80
Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls. J Clin Oncol (2007) 1.70
Physical and mental health status and health behaviors of childhood cancer survivors: findings from the 2009 BRFSS survey. Pediatr Blood Cancer (2011) 1.66
Treatment decision-making strategies and influences in patients with localized prostate carcinoma. Cancer (2005) 1.65
Suicide in patients with pancreatic cancer. Cancer (2010) 1.62
Validity of self-reported smoking status among participants in a lung cancer screening trial. Cancer Epidemiol Biomarkers Prev (2006) 1.59
Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy. J Natl Compr Canc Netw (2008) 1.55
Hyperhomocysteinemia, a cardiac metabolic disease: role of nitric oxide and the p22phox subunit of NADPH oxidase. Circulation (2005) 1.55
Investigating the role of appearance-based factors in predicting sunbathing and tanning salon use. J Behav Med (2009) 1.49
Predictors of posttraumatic growth following bone marrow transplantation for cancer. Health Psychol (2005) 1.48
Course of fatigue in women receiving chemotherapy and/or radiotherapy for early stage breast cancer. J Pain Symptom Manage (2004) 1.48
Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms. Neurobiol Aging (2006) 1.48
An outcome evaluation of the Sources of Strength suicide prevention program delivered by adolescent peer leaders in high schools. Am J Public Health (2010) 1.47
Functional impairment and the economic consequences of female breast cancer. Women Health (2002) 1.47
Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. J Clin Oncol (2005) 1.47
Proteomic contributions to personalized cancer care. Mol Cell Proteomics (2008) 1.46
Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer (2005) 1.44
Validation of the Distress Thermometer with bone marrow transplant patients. Psychooncology (2006) 1.44
A randomized controlled trial to increase cancer screening among attendees of community health centers. Ann Fam Med (2004) 1.37
A genome-wide analysis of common fragile sites: what features determine chromosomal instability in the human genome? Genome Res (2012) 1.37
Posttraumatic growth and PTSD symptomatology among colorectal cancer survivors: a 3-month longitudinal examination of cognitive processing. Psychooncology (2009) 1.31
Posttraumatic stress and posttraumatic growth in cancer survivorship: a review. Cancer J (2008) 1.30
DNA synthesis by Pol η promotes fragile site stability by preventing under-replicated DNA in mitosis. J Cell Biol (2013) 1.30
Utility of a cognitive-behavioral model to predict fatigue following breast cancer treatment. Health Psychol (2007) 1.29
Fatigue after treatment for early stage breast cancer: a controlled comparison. Cancer (2007) 1.28
Screening for psychological distress in cancer patients: challenges and opportunities. J Clin Oncol (2007) 1.27
Appearance reasons for tanning mediate the relationship between media influence and UV exposure and sun protection. Arch Dermatol (2006) 1.27
A randomized trial of generic versus tailored interventions to increase colorectal cancer screening among intermediate risk siblings. Ann Behav Med (2009) 1.26
Cancer-related fatigue. J Natl Compr Canc Netw (2010) 1.26
Appearance motives to tan and not tan: evidence for validity and reliability of a new scale. Ann Behav Med (2008) 1.25
A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancer. J Thorac Oncol (2007) 1.25
Sun-protective behavior among individuals with a family history of melanoma. Cancer Epidemiol Biomarkers Prev (2006) 1.23
Long-term results from a randomized controlled trial to increase cancer screening among attendees of community health centers. Ann Fam Med (2005) 1.23
Relationship of catastrophizing to fatigue among women receiving treatment for breast cancer. J Consult Clin Psychol (2004) 1.23
Tailored versus generic interventions for skin cancer risk reduction for family members of melanoma patients. Health Psychol (2010) 1.22
Identifying clinically meaningful fatigue with the Fatigue Symptom Inventory. J Pain Symptom Manage (2008) 1.21
Cognitive functioning in breast cancer survivors: a controlled comparison. Cancer (2009) 1.20
Enhancing research on cancer survivors. J Clin Oncol (2006) 1.20
Preliminary evaluation of a clinical syndrome approach to assessing cancer-related fatigue. J Pain Symptom Manage (2002) 1.18
The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls. Biol Blood Marrow Transplant (2009) 1.18
An investigation of appearance motives for tanning: The development and evaluation of the Physical Appearance Reasons For Tanning Scale (PARTS) and its relation to sunbathing and indoor tanning intentions. Body Image (2006) 1.16
Prevalence, predictors, and characteristics of off-treatment fatigue in breast cancer survivors. Cancer (2010) 1.16
Distress management. J Natl Compr Canc Netw (2013) 1.16
The Fatigue Symptom Inventory: a systematic review of its psychometric properties. Support Care Cancer (2010) 1.16
Associations between pain and current smoking status among cancer patients. Pain (2011) 1.13
Magnitude and correlates of response shift in fatigue ratings in women undergoing adjuvant therapy for breast cancer. J Pain Symptom Manage (2008) 1.12
Sexual functioning in long-term breast cancer survivors treated with adjuvant chemotherapy. Breast Cancer Res Treat (2002) 1.12
It's never too late to engage in lifestyle activities: significant concurrent but not change relationships between lifestyle activities and cognitive speed. J Gerontol B Psychol Sci Soc Sci (2007) 1.12
Mild cognitive impairment: incidence and vascular risk factors in a population-based cohort. Neurology (2013) 1.11
Survivorship care planning in colorectal cancer: feedback from survivors & providers. J Psychosoc Oncol (2012) 1.11
Behavioral health service utilization and preferences of older adults receiving home-based aging services. Am J Geriatr Psychiatry (2010) 1.11
Patient-provider communication and perspectives on smoking cessation and relapse in the oncology setting. Patient Educ Couns (2009) 1.11
Depression in lung cancer patients: the role of perceived stigma. Psychooncology (2010) 1.10
Ecological momentary assessment of fatigue following breast cancer treatment. J Behav Med (2004) 1.10
Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis. Support Care Cancer (2014) 1.10
Frozen hope: fertility preservation for women with cancer. J Midwifery Womens Health (2010) 1.10
Subjective cognitive complaints of older adults at the population level: an item response theory analysis. Alzheimer Dis Assoc Disord (2012) 1.09
Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison. Support Care Cancer (2012) 1.08
Evaluating the dimensionality of perceived cognitive function. J Pain Symptom Manage (2009) 1.08
Communication in the cancer 'bad news' consultation: patient perceptions and psychological adjustment. Psychooncology (2002) 1.08
Beliefs about cancer causation and prevention as a function of personal and family history of cancer: a national, population-based study. Psychooncology (2008) 1.08
Psychosocial and behavioral impact of genetic counseling and testing. Breast Dis (2007) 1.08
Improving survivorship care for patients with colorectal cancer. Cancer Control (2010) 1.08
Fatigue, depression, sleep, and activity during chemotherapy: daily and intraday variation and relationships among symptom changes. Ann Behav Med (2011) 1.07
The Florida Initiative for Quality Cancer Care: a regional project to measure and improve cancer care. Cancer Control (2009) 1.07
Responses to cancer diagnosis and treatment: posttraumatic stress and posttraumatic growth. Semin Clin Neuropsychiatry (2003) 1.07
A pilot study evaluating the effect of mindfulness-based stress reduction on psychological status, physical status, salivary cortisol, and interleukin-6 among advanced-stage cancer patients and their caregivers. J Holist Nurs (2012) 1.06
Fatigue, depression, and insomnia: evidence for a symptom cluster in cancer. Semin Oncol Nurs (2007) 1.05
The role of social and dispositional variables associated with emotional processing in adjustment to breast cancer: an internet-based study. Health Psychol (2004) 1.04
The effects of obesity and obesity-related conditions on colorectal cancer prognosis. Cancer Control (2010) 1.04
Evaluation of the functional assessment of cancer therapy cognitive scale with hematopoietic stem cell transplant patients. J Pain Symptom Manage (2007) 1.02
The CONSORT Patient-Reported Outcome (PRO) extension: implications for clinical trials and practice. Health Qual Life Outcomes (2013) 1.02
Distinct mutational behaviors differentiate short tandem repeats from microsatellites in the human genome. Genome Biol Evol (2013) 1.02
Validation of the distress thermometer worldwide: state of the science. Psychooncology (2013) 1.02
Meta-analysis of psychosocial interventions to reduce pain in patients with cancer. J Clin Oncol (2012) 1.02
The role of social cognitive processing theory and optimism in positive psychosocial and physical behavior change after cancer diagnosis and treatment. Psychooncology (2007) 1.01
A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. J Pain Symptom Manage (2002) 1.01
Exploring the differential experience of breast cancer treatment-related symptoms: a cluster analytic approach. Support Care Cancer (2007) 1.00
Cancer-Related Fatigue, Version 2.2015. J Natl Compr Canc Netw (2015) 1.00
History of major depressive disorder prospectively predicts worse quality of life in women with breast cancer. Ann Behav Med (2012) 0.99
Distress management. J Natl Compr Canc Netw (2010) 0.98
Sexual health in women treated for cervical cancer: characteristics and correlates. Gynecol Oncol (2006) 0.98
Changes in cognitive functioning in the year after hematopoietic stem cell transplantation. Cancer (2007) 0.97
Screening for psychological distress in Turkish cancer patients. Psychooncology (2007) 0.96